Skip to product information
1 of 1

AR antagonist 9

AR antagonist 9

Size

SKU:QM-0152854

Price on request
Quantity

Request quote or documents

View full details
  • Description

    AR antagonist 9 is an orally bioavailable selective androgen receptor (AR) antagonist that exerts anticancer effects by disrupting the dimerization of AR ligand-binding domains, showing potential for overcoming drug resistance in prostate cancer (PCa). Its AR antagonistic activity has an IC50 value of 0.051 μM, comparable to Enzalutamide (IC50 = 0.060 μM). AR antagonist 9 demonstrated superior efficacy against ARF876L/T877A and ARW741C mutants compared to Enzalutamide (HY-70002). Furthermore, AR antagonist 9 exhibited favorable pharmacokinetic properties, with an oral bioavailability of F = 66.24% in rats. In the LNCaP xenograft mouse model, oral administration of AR antagonist 9 significantly inhibited tumor growth. AR antagonist 9 holds promise for research into overcoming PCa drug resistance[1].

  • Molecular Formula

    C18H13F4NO2

  • Molecular Weight

    351.29

  • Smiles

    O=C1C=C(C(F)(F)F)C2=C(O1)C=C(N(CC3=CC=C(F)C=C3)C)C=C2

  • Target

    Androgen Receptor

  • Shipping Conditions

    Room temperature

Your cart
Variant Variant total Quantity Price Variant total
1 EachQM-0152854
1 EachQM-0152854
Regular price
£0.00
Sale price
£0.00/ea
£0.00
Regular price
£0.00
Sale price
£0.00/ea
£0.00

AR antagonist 9

AR antagonist 9 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.